Navigation Links
Parkinson’s Drug Linked to Gamblin

A new study finds an unusual side effect from drug therapy in some Parkinson’s patients. Certain dopamine agonists show signs of causing some patients to become excessive gamblers.
Dopamine is a chemical substance that is produced in the brain that allows people to have smooth movements. Parkinson’s patients have a severe shortage of dopamine. Drug therapies for Parkinson’s focus on increasing dopamine. //Researchers at Muhammad Ali Parkinson Research Center in Phoenix conducted a study to see if excessive gambling could be a side effect of one drug therapy.

For the study, researchers looked at the data of 1,884 patients who were seen at the center during one year. They found nine patients had gambling problems. All nine were taking levodopa and a dopamine agonist. In the brain levodopa is transformed into dopamine. The other study drug activates the dopamine receptor in the brain.

None of the patients had a previous history of gambling. Researchers say seven of the patients started gambling within one month after their dosage of the dopamine agonist was increased. All of the patients were in the advanced stages of the disease. Study authors say the gambling was severe enough to cause financial problems and two of the patients lost more than $60,000.

Researchers say after a caretaker or family member noticed the gambling problem, the patients’ drug therapies were changed. For most of the patients the new treatment plan fixed the problem. Researchers feel higher dosages of dopamine agonist may be to blame for excessive gambling. They add while the risk of this side effect is small, doctors need to inform patients about this unusual side effct.
'"/>




Page: 1

Related medicine news :

1. NPIL withdraws Parkinson’s dru
2. Delaying Parkinson’s Diseas
3. New Drug For Parkinson’s Disease With Less Side Effect
4. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
5. Magnetic Stimulation For Parkinson’s Diseas
6. Exercising regularly can reduce the risk of Parkinson’s diseas
7. Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease
8. New Medicine For Parkinson’s disease
9. A New Addition Could Help Patients With Parkinson’s Disease
10. Milk intake increases the risk of Parkinson’s disease in midlife
11. Ibuprofen to lower risk of Parkinson’s diseas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... ... in the Garden of Eden”: retells the stories of three Bible figures in modern terms. ... Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. Born in ... six, they moved to Dayton, Ohio, where Penny graduated high school. At sixteen, she ...
(Date:5/24/2017)... ... 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual board certified ... is known for his distinguished expertise and experience in the diagnosis and treatment of ... in treating renovascular disease and aortic aneurysm . He is known for his ...
(Date:5/24/2017)... Cortland, OH (PRWEB) , ... May 24, 2017 , ... ... in Cortland, OH, can now meet with Dr. Joseph Bedich for a consultation, ... smiles while simultaneously improving their oral health and functionality. , Dr. Bedich ...
(Date:5/24/2017)... ... May 24, 2017 , ... Medic CE , a ... Truth about Pediatric Septic Shock” hosted by the Journal of Emergency Medical Services (JEMS). ... Eastern time, will be presented by Captain Rommie Duckworth, LP, a career fire captain ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... prominent for-profit and nonprofit hospitals and health systems in the nation and help ... their institutions, led professional organizations and been instrumental in developing successful hospital and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based in ... Parkinson,s disease (PD), has enrolled the first patient in the ... multicenter study involving patients with PD and taking place at ... 9-to-12-month period. The first stage is open label and involves ... include Denver , Boca Raton ...
Breaking Medicine Technology: